Notice - Prescription Drug List (PDL): Esomeprazole

Notice - Prescription Drug List (PDL): Esomeprazole The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch certain uses of Esomeprazole to nonprescription status for human use by modifying the Human Prescription Drug List (PDL). 2023-09-29 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyEsomeprazolenoticenotice of intentnotifyprescription drug listPDLnonprescription status Notice - Prescription Drug List (PDL): EsomeprazoleHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-esomeprazole-1.html Notice - Prescription Drug List (PDL): EsomeprazoleHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/notice-esomeprazole.html

The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch certain uses of Esomeprazole to nonprescription status for human use by modifying the Human Prescription Drug List (PDL).

Data and Resources

Similar records